Logo 50 5791 Pill - white oval, 14mm
Generic Name: tenapanor
Pill with imprint Logo 50 5791 is White, Oval and has been identified as Ibsrela 50 mg. It is supplied by Ardelyx, Inc.
Ibsrela is used in the treatment of Irritable Bowel Syndrome with Constipation and belongs to the drug class NHE3 inhibitors. Ibsrela 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo 50 5791

Ibsrela
- Generic Name
- tenapanor
- Imprint
- Logo 50 5791
- Strength
- 50 mg
- Color
- White
- Size
- 14.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- NHE3 inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ardelyx, Inc.
- National Drug Code (NDC)
- 73154-0050
See also:
MiraLAX
MiraLAX (polyethylene glycol) is used as a laxative to treat occasional constipation or irregular ...
Linzess
Linzess (linaclotide) is used to treat chronic idiopathic constipation, irritable bowel syndrome ...
Tecvayli
Tecvayli (teclistamab) is a treatment for relapsed or refractory multiple myeloma. Includes ...
Amitiza
Amitiza (lubiprostone) is used to treat chronic constipation and irritable bowel syndrome with ...
Trulance
Trulance (plecanatide) is used to treat chronic idiopathic constipation (CIC) and irritable bowel ...
GlycoLax
GlycoLax is used for bowel preparation, constipation, constipation, acute, irritable bowel ...
ClearLax
ClearLax is used for bowel preparation, constipation, constipation, acute, irritable bowel ...
Xphozah
Xphozah (tenapanor) is a phosphate absorption inhibitor that is used lower serum phosphorus levels ...
GaviLAX
GaviLAX is used for bowel preparation, constipation, constipation, acute, irritable bowel syndrome ...
More about Ibsrela (tenapanor)
- Compare alternatives
- Pricing & coupons
- Reviews (16)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: NHE3 inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.